Eli & Co Lilly, 10% Owner at Aeglea BioTherapeutics, Inc. (AGLE), bought 2,510,924 shares at $10.00 ($5.0M) on 2016-04-12, disclosed to the SEC on 2016-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,010,924 | $0 | 0.0% |
| 2 | $10.00 | 500,000 | $5.0M | 100.0% |
| Total | $1.99 avg | 2,510,924 | $5.0M | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |